(Q33265701)

English

Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study).

scientific article

Statements

Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study). (English)
1 November 2006
1006-1013

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit